Stocks and Investing
Stocks and Investing
Mon, July 24, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Myles Minter Initiated (ARCT) at Buy and Held Target at $71 on, Jul 24th, 2023
Myles Minter of William Blair, Initiated "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy and Held Target at $71 on, Jul 24th, 2023.
Myles has made no other calls on ARCT in the last 4 months.
There are 3 other peers that have a rating on ARCT. Out of the 3 peers that are also analyzing ARCT, 0 agree with Myles's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Myles
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $51 on, Friday, July 14th, 2023
- Pete Stavropoulos of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $54 on, Friday, July 14th, 2023
- Seamus Fernandez of "Guggenheim" Maintained at Strong Buy on, Friday, July 14th, 2023
Contributing Sources